Foundry Partners LLC raised its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 18.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 140,660 shares of the company’s stock after acquiring an additional 22,145 shares during the period. Foundry Partners LLC’s holdings in Express Scripts were worth $13,364,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Omni Partners LLP raised its stake in Express Scripts by 22.0% during the 2nd quarter. Omni Partners LLP now owns 281,026 shares of the company’s stock valued at $21,698,000 after acquiring an additional 50,664 shares during the last quarter. BlackRock Inc. increased its position in Express Scripts by 1.5% during the 2nd quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock worth $2,735,103,000 after purchasing an additional 538,578 shares during the period. Marco Investment Management LLC increased its position in Express Scripts by 168.2% during the 2nd quarter. Marco Investment Management LLC now owns 79,246 shares of the company’s stock worth $6,119,000 after purchasing an additional 49,696 shares during the period. Qube Research & Technologies Ltd increased its position in Express Scripts by 45.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 11,749 shares of the company’s stock worth $907,000 after purchasing an additional 3,678 shares during the period. Finally, Commonwealth Bank of Australia increased its position in Express Scripts by 15.6% during the 2nd quarter. Commonwealth Bank of Australia now owns 296,858 shares of the company’s stock worth $22,915,000 after purchasing an additional 39,983 shares during the period. 84.73% of the stock is owned by hedge funds and other institutional investors.
ESRX has been the topic of several recent analyst reports. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday, September 18th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, September 17th. Zacks Investment Research upgraded Express Scripts from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Credit Suisse Group cut Express Scripts from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $90.00 to $96.50 in a research report on Tuesday, September 18th. Finally, Robert W. Baird cut Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a research report on Friday, July 20th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $86.36.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. The business had revenue of $25.64 billion for the quarter, compared to analysts’ expectations of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company’s revenue was up 1.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.73 EPS. Research analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.
In related news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the sale, the insider now owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.79% of the company’s stock.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: Average Daily Trade Volume – What It Means In Stock Trading
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.